ß-lactamases in Salmonella enterica isolated in Australia
DOI:
https://doi.org/10.33321/cdi.2013.37.4Keywords:
extended spectrum ß-lactamase, AmpC ß-lactamase, Salmonella enterica, Queensland, Australia, antibiotic resistance, surveillanceAbstract
Understanding the antibiotic susceptibility of Salmonella enterica is important both from a clinical treatment and a public health perspective. The emergence of extended spectrum ß-lactamases (ESßLs) and AmpC ß-lactamases in S. enterica is important, as this will limit treatment options and could provide a strain with a significant selective advantage. The aim of the study was to screen isolates of S. enterica, including isolates that had previously shown antibiotic resistance, to gauge the extent of ß-lactamase activity in S. enterica in Australia. Phenotypic detection involved screening in accordance with Clinical and Laboratory Standards Institute double disk synergy test guidelines and assessing susceptibility to cefoxitin. Presumptive positives were then screened using a MAST® AmpC & ESßL detection set. S. enterica isolates that were consecutively received in the laboratory (n=624), or had previously exhibited some antibiotic resistance (n=351), were screened for ß-lactamase activity. None of the isolates in the second group were included in the first. ß-lactamase activity was detected in nine of the consecutively received isolates; one with demonstrated ESßL activity and eight others with demonstrated AmpC ß-lactamase. ß-lactamase activity was detected in 16 of the isolates that had previously demonstrated some antibiotic resistance; three with demonstrated ESßL activity and 13 others with demonstrated AmpC ß-lactamase activity. S. enterica serovar Stanley is a serovar that is frequently acquired overseas and this serovar had the highest proportion of isolates that demonstrated ß-Lactamase activity in consecutively sampled isolates (4.95%), reflecting the emergence of an epidemic clone within South East Asia. While antibiotic resistance is being detected in Salmonella isolates, the data indicates that there is limited awareness of, or screening for, ß-lactamases in S. enterica. This study will help to overcome these deficiencies and provide some baseline surveillance data against which future trends can be measured. Commun Dis Intell 2013;37(1):47–51.
Downloads
References
Davos D. A Compendium of Laboratory Diagnostic Methods for Common and Unusual Enteric Pathogens—an Australian persective. Chapter 10, Salmonella. 2005:119–135.
Powling J. National Enteric Pathogens Surveillance Scheme: Human Annual Report 2009.
Hendriksen RS, Vieira AR, Karlsmose S, Lo Fo Wong DM, Jensen AB, Wegener HC, et al. Global monitoring of Salmonella serovar distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank: results of quality assured laboratories from 2001 to 2007. Foodborne Pathog Dis 2011;8(8):887–900.
Bright A. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: Annual report of the OzFoodNet Network, 2009. Commun Dis Intell 2010;34(No. 4):375–483.
Su L-H, Chiu C-H, Chu C, Ou JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: A global challenge. Clin Infect Dis 2004;39(4):546–551.
Bush K, Jacoby GA. Updated functional classification of ß-lactamases. Antimicrob Agents Chemother 2010;54(3):969–976.
Bush K. New ß-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001;32(7):1085–1089.
Bradford PA. Extended-spectrum ß-lactamases in the 21st Century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14(4):933–951.
Thomson KS. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 2001;7(2):333–336.
Paterson DL, Bonomo RA. Extended-spectrum ß-lactamases: a clinical update. Clin Microbiol Rev 2005;18(4):657–686.
Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002;8(5):490–495.
Hammami A, Arlet G, Ben Redjeb S, Grimont F, Ben Hassen A, Rekik A, et al. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur J Clin Microbiol Infect Dis 1991;10(8):641–646.
Batchelor M, Hopkins K, Threlfall EJ, Clifton-Hadley FA, Stallwood AD, Davies RH, et al. blaCTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005;49(4):1319–1322.
Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13(47).
Huang KY, Hong YW, Wang MH, Chu C, Su LH, Chiou CS, et al. Molecular epidemiology and antimicrobial susceptibility of Salmonella enterica serotype Stanley isolates in Taiwan. J Microbiol Immunol Infect 2007;40(5):411–418.
Kruger T, Szabo D, Keddy KH, Deeley K, Marsh JW, Hujer AM, et al. Infections with Nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa. Antimicrob Agents Chemother 2004;48(11):4263–4270.
Tassios PT, Gazouli M, Tzelepi E, Milch H, Kozlova N, Sidorenko S, et al. Spread of a Salmonella Typhimurium clone resistant to expanded-spectrum cephalosporins in three European Countries. J Clin Microbiol 1999;37(11):3774–3777.
Whichard JM, Gay K, Stevenson JE, Joyce KJ, Cooper KL, Omondi M, et al. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg Infect Dis 2007;13(11):1681–1688.
Clinical and Laboratory Standards Institute. Performance Standard for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute. P.A.Wayne. 2009.
Clinical and Laboratory Standards Institute. Performance Standard for Antimicrobial Disc Susceptibility Tests; Approved Standards – Tenth Edition, CLSI document M02-10. Clinical and Laboratory Standards Institute. P.A.Wayne. 2009.
Livermore DM, Brown DFJ. Detection of ß-lactamase-mediated resistance. J Antimicrob Chemother 2001;48(Suppl 1):59–64.
Hanson ND, Moland ES, Hossain A, Neville SA, Gosbell IB, Thomson KS. Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases. J Antimicrob Chemother 2002;49(6):1011–1014.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2013 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
